# clm_97459A7EC040

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: quarterly_revenue  
value: 6,805,600,000 United States dollar  
valid_from: 2021-03-31  
valid_to: 2021-06-30  
published: 2021-04-30  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_77D077A608D2  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company quarterly revenue: 6,805,600,000 United States dollar", as of 2021-03-31 (until 2021-06-30). Claim clm_97459A7EC040, https://asof.is/claim/clm_97459A7EC040, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947821000122/0000059478-21-000122-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:Revenues in 10-Q Q1 FY2021, filed 2021-04-30  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947821000122/0000059478-21-000122-index.htm (primary, SEC EDGAR 10-Q Q1 FY2021, published 2021-04-30)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_revenue | 5,740,600,000 United States dollar | valid 2020-09-30 to 2021-03-31 | conf 0.95 | superseded | superseded_by [clm_97459A7EC040](/claim/clm_97459A7EC040.md) | [clm_66B1C3D114E4](/claim/clm_66B1C3D114E4.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.